AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 5, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Breast Fat Grafting Retention
Interventions
DEVICE

AuraGen 1-2-3 with AuraClens

Autologous fat transfer (AFT) is a minimally invasive medical procedure that includes aspirating adipose tissue from one part of the body, and washing, filtering and re-injecting the processed fat tissue into a different part of the body with the primary purpose of adding volume. The AuraGen 1-2-3 with AuraClens is a lipoaspirate wash system designed to be used in the operating room in conjunction with a user-provided liposuction cannular, a vacuum source, and waste canister.

Trial Locations (15)

10017

NYU Langone Plastic Surgery Associates, New York

10021

Luxurgery, New York

28078

Hunstad Kortesis Bharti Cosmetic Surgery, Huntersville

33176

Baptist Miami / Miami Cancer Institute, Miami

40222

Calo Aesthetics, Louisville

46290

Meridian Plastic Surgery, Carmel

66223

Ascentist Plastic Surgery, Overland Park

70002

Dallas Plastic Surgery, Metairie

75082

Regional Plastic Surgery, Richardson

75205

Dallas Plastic Surgery, University Park

78705

Restora Austin, Austin

85251

Tessler Plastic Surgery, Scottsdale

90210

Aura Aesthetica, Inc., Beverly Hills

98004

Bellevue Plastic Surgery, Bellevue

07784

V Plastic Surgery, West Long Branch

All Listed Sponsors
lead

Tiger Biosciences, LLC.

INDUSTRY